157 related articles for article (PubMed ID: 32184843)
1. Development of 1,2,4-Triazole-5-Thione Derivatives as Potential Inhibitors of Enoyl Acyl Carrier Protein Reductase (InhA) in Tuberculosis.
Vora D; Upadhyay N; Tilekar K; Jain V; Ramaa CS
Iran J Pharm Res; 2019; 18(4):1742-1758. PubMed ID: 32184843
[TBL] [Abstract][Full Text] [Related]
2. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
Saharan VD; Mahajan SS
Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
[TBL] [Abstract][Full Text] [Related]
3. Tryptanthrin Analogues as Inhibitors of Enoyl-acyl Carrier Protein Reductase: Activity against Mycobacterium tuberculosis, Toxicity, Modeling of Enzyme Binding.
Duca G; Pogrebnoi S; Boldescu V; Aksakal F; Uncu A; Valica V; Uncu L; Negres S; Nicolescu F; Macaev F
Curr Top Med Chem; 2019; 19(8):609-619. PubMed ID: 30834838
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides.
He X; Alian A; Ortiz de Montellano PR
Bioorg Med Chem; 2007 Nov; 15(21):6649-58. PubMed ID: 17723305
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, in vitro and in silico evaluation of novel substituted 1,2,4-triazole analogues as dual human VEGFR-2 and TB-InhA inhibitors.
Zawal AG; Abdel-Aziz MM; Elbatreek MH; El-Shanawani AA; Abdel-Aziz LM; Elbaramawi SS
Bioorg Chem; 2023 Dec; 141():106883. PubMed ID: 37774433
[TBL] [Abstract][Full Text] [Related]
6. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling.
Kassem AF; Sabt A; Korycka-Machala M; Shaldam MA; Kawka M; Dziadek B; KuzioĊa M; Dziadek J; Batran RZ
Bioorg Chem; 2024 May; 150():107511. PubMed ID: 38870705
[TBL] [Abstract][Full Text] [Related]
7. Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA).
Khaleel EF; Sabt A; Korycka-Machala M; Badi RM; Son NT; Ha NX; Hamissa MF; Elsawi AE; Elkaeed EB; Dziadek B; Eldehna WM; Dziadek J
Bioorg Chem; 2024 Mar; 144():107138. PubMed ID: 38262087
[TBL] [Abstract][Full Text] [Related]
8. Isatin-pyrimidine hybrid derivatives as enoyl acyl carrier protein reductase (InhA) inhibitors against Mycobacterium tuberculosis.
Khalifa A; Khalil A; Abdel-Aziz MM; Albohy A; Mohamady S
Bioorg Chem; 2023 Sep; 138():106591. PubMed ID: 37201321
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
Lokesh BVS; Prasad YR; Shaik AB
Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
[TBL] [Abstract][Full Text] [Related]
10. Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking.
El Sawy MA; Elshatanofy MM; El Kilany Y; Kandeel K; Elwakil BH; Hagar M; Aouad MR; Albelwi FF; Rezki N; Jaremko M; El Ashry ESH
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563096
[TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis and Molecular Docking of Novel Acetophenone-1,2,3-Triazoles Containing Compounds as Potent Enoyl-Acyl Carrier Protein Reductase (InhA) Inhibitors.
Albelwi FF; Abdu Mansour HM; Elshatanofy MM; El Kilany Y; Kandeel K; Elwakil BH; Hagar M; Aouad MR; El Ashry ESH; Rezki N; El Sawy MA
Pharmaceuticals (Basel); 2022 Jun; 15(7):. PubMed ID: 35890098
[TBL] [Abstract][Full Text] [Related]
12. Discovery of novel N-methyl carbazole tethered rhodanine derivatives as direct inhibitors of Mycobacterium tuberculosis InhA.
Shaikh MS; Kanhed AM; Chandrasekaran B; Palkar MB; Agrawal N; Lherbet C; Hampannavar GA; Karpoormath R
Bioorg Med Chem Lett; 2019 Aug; 29(16):2338-2344. PubMed ID: 31227345
[TBL] [Abstract][Full Text] [Related]
13. Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Eur J Med Chem; 2014 Oct; 86():613-27. PubMed ID: 25218910
[TBL] [Abstract][Full Text] [Related]
14. Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Pedgaonkar GS; Sridevi JP; Jeankumar VU; Saxena S; Devi PB; Renuka J; Yogeeswari P; Sriram D
Bioorg Med Chem; 2014 Nov; 22(21):6134-45. PubMed ID: 25282650
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Inhibitor of Enoyl-Acyl Carrier Protein Reductase (InhA) Enzyme in
Singh K; Pandey N; Ahmad F; Upadhyay TK; Islam MH; Alshammari N; Saeed M; Al-Keridis LA; Sharma R
Antibiotics (Basel); 2022 Aug; 11(8):. PubMed ID: 36009907
[No Abstract] [Full Text] [Related]
16. Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis.
Matviiuk T; Rodriguez F; Saffon N; Mallet-Ladeira S; Gorichko M; de Jesus Lopes Ribeiro AL; Pasca MR; Lherbet C; Voitenko Z; Baltas M
Eur J Med Chem; 2013; 70():37-48. PubMed ID: 24140915
[TBL] [Abstract][Full Text] [Related]
17. Piperazine derivatives: synthesis, inhibition of the Mycobacterium tuberculosis enoyl-acyl carrier protein reductase and SAR studies.
Rotta M; Pissinate K; Villela AD; Back DF; Timmers LF; Bachega JF; de Souza ON; Santos DS; Basso LA; Machado P
Eur J Med Chem; 2015 Jan; 90():436-47. PubMed ID: 25461892
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential inhibitors of
Kamera S; Sharma VK; Prasad V B; Garlapati A
J Biomol Struct Dyn; 2023 Aug; ():1-15. PubMed ID: 37526169
[TBL] [Abstract][Full Text] [Related]
19. Novel diaryl ether derivatives as InhA inhibitors: Design, synthesis and antimycobacterial activity.
Abdelaziz OA; Othman DIA; Abdel-Aziz MM; Badr SMI; Eisa HM
Bioorg Chem; 2022 Dec; 129():106125. PubMed ID: 36126606
[TBL] [Abstract][Full Text] [Related]
20. Anti-Tubercular Properties of 4-Amino-5-(4-Fluoro-3- Phenoxyphenyl)-4
Venugopala KN; Kandeel M; Pillay M; Deb PK; Abdallah HH; Mahomoodally MF; Chopra D
Antibiotics (Basel); 2020 Aug; 9(9):. PubMed ID: 32878018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
